2011
DOI: 10.3390/pharmaceutics3020186
|View full text |Cite
|
Sign up to set email alerts
|

Design, Synthesis, and Biological Evaluation of PKD Inhibitors

Abstract: Protein kinase D (PKD) belongs to a family of serine/threonine kinases that play an important role in basic cellular processes and are implicated in the pathogenesis of several diseases. Progress in our understanding of the biological functions of PKD has been limited due to the lack of a PKD-specific inhibitor. The benzoxoloazepinolone CID755673 was recently reported as the first potent and kinase-selective inhibitor for this enzyme. For structure-activity analysis purposes, a series of analogs was prepared a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
38
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(38 citation statements)
references
References 72 publications
(86 reference statements)
0
38
0
Order By: Relevance
“…The recent development of selective benzoxoloazepinolone PKD inhibitor (Fig. 5 and 7) should accelerate research in this area (22,(35)(36)(37). The compound is a potent and cell-permeable inhibitor of PKD.…”
Section: Discussionmentioning
confidence: 99%
“…The recent development of selective benzoxoloazepinolone PKD inhibitor (Fig. 5 and 7) should accelerate research in this area (22,(35)(36)(37). The compound is a potent and cell-permeable inhibitor of PKD.…”
Section: Discussionmentioning
confidence: 99%
“…8). [23][24][25] Several lead structures, The pH was measured electrochemically after excess compound had been filtered from the solution.…”
mentioning
confidence: 99%
“…Compared with DAG, the effect of PKD can be addressed more specifically using selective inhibitors. The PKD inhibitors used here have been shown to inhibit PKD selectively, with little effect on PKC (9,33).…”
Section: Discussionmentioning
confidence: 96%
“…No statistical difference in cell capacitance was found between groups in this or any other figure. for the same period of time. To inhibit protein kinase D (PKD), we added either CID-755673 or CID-2011756 (Tocris, Bristol, UK; 40 M) to the cultures for 6 h (9,33,34,48), and control cells received DMSO (0.05%). The effect of PMA (Sigma-Aldrich; 50 nM) was also tested by adding the drug to the cultures for 6 h, and control cells received DMSO vehicle (0.05%).…”
Section: Methodsmentioning
confidence: 99%